It is unclear why the DDR signaling alterations varied between the MTH1-defective NSCLC lines (Fig. 3), but given that different cancers already harbour many other mutations and potentially DDR defects, the signaling variances may simply reflect the differing abilities and deficiencies in DDR functions in different cancers. This evidence concerns the gene NUDT1 and cancer.